The written description requirement is a critical and often contentious issue in life sciences patent law. In biotechnology and pharmaceutical patents, meeting this requirement can be challenging due to the complexity and unpredictability of biological inventions. Because courts and patent offices worldwide continue to refine what is necessary to satisfy written description obligations, it is crucial for inventors and practitioners to stay informed. WRITTEN DESCRIPTION IN LIFE SCIENCES PATENTS: AVOIDING OVERREACH
Made with FlippingBook Annual report maker